UCL Therapeutic Innovation Networks


Repurposing TIN Seminar: Overcoming Regulatory & Financial Hurdles to Reposition Approved Drugs

20 October 2020, 2:00 pm–3:30 pm

repurposing event banner

This second Repurposing TIN seminar of the series will focus on the commercial considerations to feed into a drug repurposing strategy.

This event is free.

Event Information

Open to







Alina Shrourou

Drug repurposing can be a cost effective reduced-risk strategy for developing new drug products and can offer opportunities for shelved or abandoned drugs. However the commercial success of a repurposed drug depends on obtaining effective protection against competitors through intellectual property (IP) and regulatory exclusivities.

In the second webinar of this TIN seminar series, we will focus on the commercial considerations to feed into a drug repurposing strategy in order to maximise the repositioning opportunities for previously marketed drugs. We will also talk about the challenges drug developers are presented with and the provisions offered by the regulatory framework to incentivise the repurposing of approved medicines for the benefit of public health.

Speakers and running order:

  • Dr Asha Recino (TIN Coordinator)
  • Prof. Oscar Della Pasqua (Repurposing TIN Chair)
  • Dr David Phillips (Senior Business Manager, UCLB)
  • Dr Daniel O’Connor (Medical Assessor, MHRA)
  • Q&A: 20 mins

Basic and translational researchers from across UCL are encouraged to attend. The Repurposing TIN aims to reach out to researchers at all career stages currently involved/or planning to work in the Drug Repurposing space and interested in having a framework to navigate the regulatory environment and intellectual property laws to commercialize drugs that are already on the market.

We'd also like to invite existing and potential industry partners to attend as we provide insights into the work of the TINs and are looking for collaborators to accelerate translation.

About the Speaker

at UCL